ATE131047T1 - Osteogenesis-stimulierende mittel. - Google Patents

Osteogenesis-stimulierende mittel.

Info

Publication number
ATE131047T1
ATE131047T1 AT90914433T AT90914433T ATE131047T1 AT E131047 T1 ATE131047 T1 AT E131047T1 AT 90914433 T AT90914433 T AT 90914433T AT 90914433 T AT90914433 T AT 90914433T AT E131047 T1 ATE131047 T1 AT E131047T1
Authority
AT
Austria
Prior art keywords
osteogenesis
stimulant agents
stimulant
agents
carnosine
Prior art date
Application number
AT90914433T
Other languages
English (en)
Inventor
Masayoshi Yamaguchi
Original Assignee
Zeria Pharm Co Ltd
Hamari Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharm Co Ltd, Hamari Chemicals Ltd filed Critical Zeria Pharm Co Ltd
Application granted granted Critical
Publication of ATE131047T1 publication Critical patent/ATE131047T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT90914433T 1989-10-02 1990-09-28 Osteogenesis-stimulierende mittel. ATE131047T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1255325A JP2811331B2 (ja) 1989-10-02 1989-10-02 骨形成促進剤

Publications (1)

Publication Number Publication Date
ATE131047T1 true ATE131047T1 (de) 1995-12-15

Family

ID=17277215

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90914433T ATE131047T1 (de) 1989-10-02 1990-09-28 Osteogenesis-stimulierende mittel.

Country Status (8)

Country Link
US (1) US5294634A (de)
EP (1) EP0495106B1 (de)
JP (1) JP2811331B2 (de)
KR (1) KR0147855B1 (de)
AT (1) ATE131047T1 (de)
CA (1) CA2067374C (de)
DE (1) DE69024060T2 (de)
WO (1) WO1991004737A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2811353B2 (ja) * 1990-07-06 1998-10-15 ゼリア新薬工業株式会社 炎症性腸疾患予防・治療剤
EP1285660A4 (de) * 2000-05-31 2003-07-09 Hamari Chemicals Ltd Zinksupplement-zusammensetzungen zur oralen verabreichung
US9492584B2 (en) 2009-11-25 2016-11-15 Difusion Technologies, Inc. Post-charging of zeolite doped plastics with antimicrobial metal ions
US8821912B2 (en) 2009-12-11 2014-09-02 Difusion Technologies, Inc. Method of manufacturing antimicrobial implants of polyetheretherketone
EP2523672B1 (de) 2010-01-15 2016-07-13 Rutgers, the State University of New Jersey Verwendung von vanadiumverbindungen für beschleunigte knochenheilung
BR112012026636B1 (pt) 2010-05-07 2019-01-15 Difusion Technologies, Inc. implantes médicos com hidrofilicidade aumentada e método para minimizar a formação de biofilme em um paciente
US20140322292A1 (en) 2010-12-10 2014-10-30 Rutgers, The State University Of New Jersey Insulin-mimetics as therapeutic adjuncts for bone regeneration
CN103781358A (zh) 2010-12-10 2014-05-07 新泽西医科和牙科大学 涂布有胰岛素模拟剂复合材料的可植入装置及其方法
US9931348B2 (en) 2011-07-06 2018-04-03 Rutgers, The State University Of New Jersey Vanadium compounds as therapeutic adjuncts for cartilage injury and repair

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63229058A (ja) * 1987-03-17 1988-09-22 大鳥　泰雅 骨形成材料の製法
JPH0717505B2 (ja) * 1989-02-23 1995-03-01 絹子 永井 骨粗鬆症予防剤

Also Published As

Publication number Publication date
KR0147855B1 (ko) 1998-08-17
EP0495106A1 (de) 1992-07-22
EP0495106A4 (en) 1992-09-30
DE69024060T2 (de) 1996-08-01
WO1991004737A1 (fr) 1991-04-18
EP0495106B1 (de) 1995-12-06
CA2067374C (en) 2000-07-04
JPH03120257A (ja) 1991-05-22
US5294634A (en) 1994-03-15
CA2067374A1 (en) 1991-04-03
KR920703050A (ko) 1992-12-17
JP2811331B2 (ja) 1998-10-15
DE69024060D1 (de) 1996-01-18

Similar Documents

Publication Publication Date Title
DE59010810D1 (de) Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure
DE59400489D1 (de) Fungizide Wirkstoffkombinationen
TW234691B (de)
ATE182786T1 (de) Pharmazeutische und/oder kosmetische zubereitung
DK261490D0 (da) New pharmaceutical compound
DE69322251D1 (de) Medizinische zusammensetzung
ATE131047T1 (de) Osteogenesis-stimulierende mittel.
ATE81004T1 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
MY104942A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2-ones.
DE68907566D1 (de) Phenoxy- und phenylthio-, amino-substituierte benzocyclo-alkan-derivate bei der behandlung und verhuetung von arzneimittelresistenten protozoen-infektionen.
ES8707553A1 (es) Procedimiento para la obtencion de un peptido.
IT1198238B (it) Composti ad attivita' antibiotica
IT1216104B (it) Peptidi ad attivita' farmaceutica.
EP0266559A3 (en) Therapeutic agent for the treatment of peptic ulcer disease
IT1216096B (it) L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.
FR2579463B1 (fr) Composition therapeutique a base d'imidazolidinyluree pour le traitement des manifestations cutanees de l'acne
IT1216103B (it) Peptidi ad attivita' farmaceutica.
IT8622051A1 (it) Composizioni farmaceutiche ad attivita' cicatrizzante
EP0448726A4 (en) 2-substituted 2-cyclopentenone and carcinostatic agent and osteogenesis promoter containing the same as active ingredient
ATE60578T1 (de) Prostacyclinanalog, dieses als aktives bestandteil enthaltendes, den blutumlauf verbesserndes mittel und gegen magengeschwuere wirkendes mittel.
SU1319521A1 (ru) 5-(2,2,2-Трифтор-1-окси-1-трифторметилэтил)фурил-2-метилгидразонийбромид, проявляющий антимикробную и противовоспалительную активность
ATE15645T1 (de) Als aktiven zusatz alpha-benzylapfelsaeure enthaltende immunomodulatoren.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee